NCFB: a chronic lung disease

Non-Cystic Fibrosis Bronchiectasis (NCFB) is a chronic lung disease with currently no FDA-approved treatment. Patients suffer from persistent cough, excess sputum production and frequent respiratory infections.

No US approved therapy

NCFB is characterized by dilated airways inflamed with thick phlegm. Some patients suffer exacerbations, sudden severe flare-ups of symptoms that often require hospitalization and cause further permanent damage to the lungs.

Currently, no treatments are specifically approved in the US for this condition and physicians currently use bronchodilators, antibiotics, steroids, mucus thinners and surgery to treat patients.

Developing novel therapeutics for respiratory diseases

We welcome inquires from healthcare professionals seeking to learn more.